UA82564C2 - Антиретровирусная фармацевтическая композиция замедленного высвобождения и способ ее изготовления - Google Patents

Антиретровирусная фармацевтическая композиция замедленного высвобождения и способ ее изготовления Download PDF

Info

Publication number
UA82564C2
UA82564C2 UAA200604821A UAA200604821A UA82564C2 UA 82564 C2 UA82564 C2 UA 82564C2 UA A200604821 A UAA200604821 A UA A200604821A UA A200604821 A UAA200604821 A UA A200604821A UA 82564 C2 UA82564 C2 UA 82564C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutically acceptable
composition
composition according
controlled release
zidovudine
Prior art date
Application number
UAA200604821A
Other languages
English (en)
Ukrainian (uk)
Inventor
Химадри Сэн
Сурьякумар Джаянтхи
Винеетх Рагхаван
Ганга Сринивас Арра
Original Assignee
Люпин Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Люпин Лимитед filed Critical Люпин Лимитед
Publication of UA82564C2 publication Critical patent/UA82564C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к антиретровирусной фармацевтической композиции из трех лекарственных препаратов, обеспечивающей сочетание замедленного и немедленного высвобождения действующих ингредиентов. Композиция обеспечивает поступление требуемых доз действующих ингредиентов ламивудина, зидовудина или их фармацевтически приемлемых производных, а также немедленное высвобождение как минимум одного избирательного ингибитора обратной транскриптазы ненуклеозидной природы (NNRTI), предпочтительно невирапина или его фармацевтически приемлемого производного с фармацевтически приемлемыми вспомогательными ингредиентами. Композиция требует однократного суточного приема, что способствует соблюде
UAA200604821A 2003-10-01 2004-09-29 Антиретровирусная фармацевтическая композиция замедленного высвобождения и способ ее изготовления UA82564C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN417MU2003 2003-10-01
PCT/IN2004/000306 WO2005048978A2 (en) 2003-10-01 2004-09-29 A controlled release pharmaceutical composition and a process for preparing the same

Publications (1)

Publication Number Publication Date
UA82564C2 true UA82564C2 (ru) 2008-04-25

Family

ID=34611194

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200604821A UA82564C2 (ru) 2003-10-01 2004-09-29 Антиретровирусная фармацевтическая композиция замедленного высвобождения и способ ее изготовления

Country Status (13)

Country Link
US (1) US20070231385A1 (ru)
EP (1) EP1673072B1 (ru)
CN (1) CN1863512A (ru)
AP (1) AP1826A (ru)
AT (1) ATE358470T1 (ru)
BR (1) BRPI0415322A (ru)
DE (1) DE602004005734T2 (ru)
EA (1) EA008944B1 (ru)
ES (1) ES2286716T3 (ru)
MX (1) MXPA06003479A (ru)
UA (1) UA82564C2 (ru)
WO (1) WO2005048978A2 (ru)
ZA (1) ZA200603421B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006114709A1 (en) * 2005-04-25 2006-11-02 Aurobindo Pharma Limited Pharmaceutical compositions of antiretrovirals
BRPI0811732A2 (pt) 2007-06-08 2014-11-18 Boehring Ingelheim Internat Gmbh Formulação de liberação prolongada de nevirapina
EP2453759B1 (en) * 2009-07-14 2015-10-21 Hill's Pet Nutrition, Inc. Pet food compositions including a sustained-release lipoic acid and methods of manufacture and use thereof
CN102247332B (zh) * 2011-01-27 2015-03-25 济南久创化学有限责任公司 一种拉米夫定片及其制备方法
CN102225069B (zh) * 2011-04-29 2013-05-08 陶珍珠 一种耐药性显著降低的药物组合物及其制备方法和其应用
CA2835272A1 (en) * 2011-05-30 2012-12-06 Cipla Limited Pharmaceutical antiretroviral composition
WO2013111147A1 (en) * 2011-12-19 2013-08-01 Hetero Research Foundation Extended release compositions of nevirapine
CN107334743B (zh) * 2016-07-15 2020-04-21 安徽贝克生物制药有限公司 一种齐多夫定、拉米夫定、奈韦拉平复方片及其制备方法
CN114392239B (zh) * 2022-01-10 2023-06-27 安徽贝克生物制药有限公司 一种拉米夫定、齐多夫定和依非韦伦的复方片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556141A (ru) * 1956-03-27
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US6177435B1 (en) * 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
GB9821000D0 (en) * 1998-09-28 1998-11-18 Glaxo Group Ltd Antiviral combinations
ZA200110500B (en) * 2001-05-11 2002-04-03 Cipla Medpro Pty Ltd Pharmaceutical composition.

Also Published As

Publication number Publication date
MXPA06003479A (es) 2006-06-08
EA200600679A1 (ru) 2006-08-25
ATE358470T1 (de) 2007-04-15
EP1673072A2 (en) 2006-06-28
EP1673072B1 (en) 2007-04-04
ZA200603421B (en) 2007-09-26
DE602004005734T2 (de) 2007-12-27
US20070231385A1 (en) 2007-10-04
DE602004005734D1 (de) 2007-05-16
BRPI0415322A (pt) 2006-12-05
ES2286716T3 (es) 2007-12-01
WO2005048978A3 (en) 2006-02-23
WO2005048978A2 (en) 2005-06-02
AP1826A (en) 2008-02-08
EA008944B1 (ru) 2007-10-26
AP2006003597A0 (en) 2006-04-30
CN1863512A (zh) 2006-11-15

Similar Documents

Publication Publication Date Title
FI3804715T3 (fi) Farmaseuttinen yhdistelmä, koostumus ja yhdistelmävalmiste, joka käsittää glukokinaasin aktivaattorin ja dpp-iv:n estäjän ja niiden valmistusmenetelmä ja käyttö
US20100203133A1 (en) High drug load tablet
KR20020075801A (ko) 울혈성 심부전 치료의 부분적 지방산 산화 방지제
KR20100069685A (ko) 아세트아미노펜과 트라마돌의 지속 방출을 위한 이중층 조성물
RU2664422C2 (ru) Комбинированный препарат, содержащий гемиглиптин и метформин, и способ его получения
AU2014299447B2 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
UA82564C2 (ru) Антиретровирусная фармацевтическая композиция замедленного высвобождения и способ ее изготовления
CA2835272A1 (en) Pharmaceutical antiretroviral composition
EP4667003A2 (en) Bi-layer pharmaceutical tablet formulation
US20240041882A1 (en) Mini-tablet dosage form of a viral terminase inhibitor and uses thereof
US20210290548A1 (en) Formulations of raltegravir
WO2022228735A1 (en) Pharmaceutical composition comprising a combination of sitagliptin and metformin and method of preparation thereof
WO2017029226A1 (en) Solid pharmaceutical composition of abacavir, lamivudine, and efavirenz
US20030004130A1 (en) Homogeneous pharmaceutical compositions containing zidovudine and lamivudine
US20080145422A1 (en) Galantamine tablet formulation
RU2247561C1 (ru) Комбинированная фармацевтическая композиция с противотуберкулёзным действием
WO2019145926A1 (en) Stable thiamine containing pharmaceutical formulations
SK50222004A3 (sk) Kompozície matrice s modifikovaným uvoľňovaním, s dlhodobým účinkom
CN112569356B (zh) 一种含有利尿剂的药物组合物
HK40027621A (en) Stable thiamine containing pharmaceutical formulations
SK284769B6 (sk) Farmaceutické formulácie obsahujúce pentaerytrityltetranitrát alebo jeho metabolity a spôsob jeho prípravy
KR20080054394A (ko) 프랄나카산의 지연 방출 제형
JP2006509789A (ja) 不安症治療法及び治療薬
AU2010200509A1 (en) High drug load tablet